![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07K 16/28 | |
A61K 39/395 | |||
A61K 45/06 | |||
C07K 16/00 | |||
C07K 14/47 | |||
A61K 39/00 | |||
A61K 31/573 |
(11) | Number of the document | 2598533 |
(13) | Kind of document | T |
(96) | European patent application number | 11813204.2 |
Date of filing the European patent application | 2011-07-28 | |
(97) | Date of publication of the European application | 2013-06-05 |
(45) | Date of publication and mention of the grant of the patent | 2019-02-20 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2011/045768 |
Date | 2011-07-28 |
(87) | Number | WO 2012/016073 |
Date | 2012-02-02 |
(30) | Number | Date | Country code |
368465 P | 2010-07-28 | US |
(72) |
BLOCK, David S., US
OLSEN, Henrik, US
|
(73) |
Gliknik Inc.,
801 W. Baltimore Street, Suite 501A, Baltimore, MD 21201,
US
|
(54) | FUSION PROTEINS OF NATURAL HUMAN PROTEIN FRAGMENTS TO CREATE ORDERLY MULTIMERIZED IMMUNOGLOBULIN FC COMPOSITIONS |
FUSION PROTEINS OF NATURAL HUMAN PROTEIN FRAGMENTS TO CREATE ORDERLY MULTIMERIZED IMMUNOGLOBULIN FC COMPOSITIONS |